Mayo Clinic College of Medicine and Science (Jacksonville) Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 225
• Acute Myeloid Leukemia Research 170
• CAR-T cell therapy research 166
• Hematopoietic Stem Cell Transplantation 133
• Lymphoma Diagnosis and Treatment 127
• Chronic Lymphocytic Leukemia Research 123
• Cancer Immunotherapy and Biomarkers 93
• Lung Cancer Treatments and Mutations 51
• Prostate Cancer Treatment and Research 43
• Acute Lymphoblastic Leukemia research 35
• Sarcoma Diagnosis and Treatment 35
• Pancreatic and Hepatic Oncology Research 34

Most cited

1. Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.

   The New England journal of medicine · 2023 · 653 citations · Sikander Ailawadhi

2. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes.

   Current drug targets · 2021 · 574 citations · Firas Baidoun

3. Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

   Blood · 2025 · 135 citations · Ricardo Parrondo

4. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.

   The New England journal of medicine · 2022 · 456 citations · Mohamed Dabaja

5. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.

   Lancet (London, England) · 2024 · 258 citations · Steven Attia

6. Next generation of immune checkpoint inhibitors and beyond.

   Journal of hematology & oncology · 2021 · 454 citations · Yanyan Lou

7. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.